A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib. (Q52895363)
scientific article published on 14 December 2015
Language:
Current Data About A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib.
(P31) (Q13442814)
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P304) 2139-2145
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P407) (Q1860)

(P433) 9
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P478) 22
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P577) Monday, December 14, 2015
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P921) (Q418369)
(P887)

(P1433) (Q332253)
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P1476) "A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib." (language: en)
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

(P2093) Ji Yun Lee
(P1545) 1
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Jong-Mu Sun
(P1545) 2
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Sung Hee Lim
(P1545) 3
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Hae Su Kim
(P1545) 4
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Kwai Han Yoo
(P1545) 5
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Ki Sun Jung
(P1545) 6
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Haa-Na Song
(P1545) 7
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Bo Mi Ku
(P1545) 8
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Jiae Koh
(P1545) 9
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Yeon-Hee Bae
(P1545) 10
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Se-Hoon Lee
(P1545) 11
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Jin Seok Ahn
(P1545) 12
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Keunchil Park
(P1545) 13
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

Myung-Ju Ahn
(P1545) 14
(P248)
(P698) 26667485
(P813) Wednesday, May 9, 2018
(P854) http://europepmc.org/abstract/MED/26667485

other details
description scientific article published on 14 December 2015

External Links
(P356) 10.1158/1078-0432.CCR-15-1653
(P698) 26667485